• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FRESENIUS MEDICAL CARE NORTH AMERICA CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FRESENIUS MEDICAL CARE NORTH AMERICA CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 03-2722-9
Device Problems Fluid/Blood Leak (1250); Loose or Intermittent Connection (1371)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/26/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4) the reported complaint was not confirmed as the complaint device was not available for manufacturer evaluation.As such, a definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.A records review was performed on the reported lot.An investigation of the device manufacturing records was conducted by the manufacturer.There were no deviations or non-conformances identified during the manufacturing process which could be associated with the reported event.In addition, the batch record review confirmed the labeling, material, and process controls were within specification.The lot passed all release criteria.Review of the batch production record (bpr) did not reveal a probable cause for the customer complaint.
 
Event Description
A user facility reported that an external blood leak occurred while a patient was undergoing a hemodialysis (hd) treatment.The blood leak was observed where the line connected to the injection site.Reportedly, the leak allowed air to enter the lines which led to a machine alarm being generated.The patient's estimated blood loss (ebl) was noted as being approximately 300ml, or the amount of blood within the extracorporeal circuit.No patient adverse effects were experienced and no medical intervention was required.The patient was setup with new supplies on the same machine, and then the treatment was continued.The treatment was successfully completed with no further issues.Follow-up information was provided which noted that damage was present to the bloodline.The complaint device is available to be returned to the manufacturer for evaluation.Although requested, the device has not been received.
 
Manufacturer Narrative
The complaint device was returned to the manufacturer for physical evaluation.Two samples were returned to the manufacturer inside of a bag identified with code number (b)(4), lot number 16br01431.The samples consisted of portions of the tubes assembled to the arterial injection site.A visual inspection of the two returned devices revealed a crack in one of the arterial injection sites and no crack or defect observed in the second device.The two devices were subjected to a functional leak test, which confirmed the alleged failure that the device with the crack consequently led to the set leaking.The second device without the crack passed the functional leak test and no leaks were observed.The crack in one of the returned devices is attributed to a defective supplier part or to the application of excessive force on the injection site.A records review was performed on the reported lot.An investigation of the device manufacturing records was conducted by the manufacturer.There were no deviations or non-conformances identified during the manufacturing process which could be associated with the reported event.In addition, the batch record review confirmed the labeling, material, and process controls were within specification.The lot passed all release criteria.The reported complaint of a fluid leak in the line was confirmed.A visual examination of the two returned devices identified a crack in one of the devices.Although no defect was identified with the second bloodline product returned, this complaint has been deemed confirmed, based on the investigation findings which revealed the presence of a leak at the location of the observed crack.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUSTOM COMBI SET
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
FRESENIUS MEDICAL CARE NORTH AMERICA
mike allen #1331
parque industrial reynosa
reynosa, tamaulipas cp 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S. A. DE C. V.
mike allen #1331
parque industrial reynosa
reynosa, tamaulipas cp 88780
MX   88780
Manufacturer Contact
thomas johnson
920 winter st.
waltham, MA 02451
7816999000
MDR Report Key5903735
MDR Text Key54046089
Report Number8030665-2016-00440
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
Report Date 09/29/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2019
Device Catalogue Number03-2722-9
Device Lot Number16BR01431
Other Device ID Number00840861100293
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/12/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/31/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/27/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-